Italy· 050825037
AQUIPTA*28 cpr 60 mg
A atogepant product containing atogepant, registered in Italy by ABBVIE DEUTSCHLAND GmbH&CO.KG, on the national reimbursement list. The same ATC class is registered in 16 of our 19 countries.
Checked against the register on
Informational only — not a medical device.
Where it is registered
Atogepant is registered in 16 of 19 countries.
Countries holding a registration under ATC N02CD07 (atogepant), each read from that country’s own register.
- This record: Italy
- 11 of them publish a price we can compare per daily dose
Atogepant · ATC N02CD07
16 / 19 countries
- Belgiumprice
- Canada
- Czechiaprice
- Denmark
- Finlandprice
- Franceprice
- Icelandprice
- Ireland
- Italyprice
- Netherlands
- Norwayprice
- Polandprice
- Spainprice
- Switzerlandprice
- United Kingdom
- United Statesprice
Price per daily dose
What a daily dose of atogepant costs, country by country.
Normalised to the WHO defined daily dose (60 mg), so markets compare like for like.
- Italy: $96.51 per daily dose (median across products in the class)
- Public list prices, converted to USD at the rate date shown
Atogepant · price per daily dose (60 mg)
USD · FX 28 Sept 2026
- IT Italy$96.51
- CH Switzerland$95.15
The record
At a glance
- Active substance
- Atogepant
- Manufacturer
- ABBVIE DEUTSCHLAND GmbH&CO.KG
- Country
- Italy (IT)
- ATC code
- N02CD07
- ATC class
- Atogepant
- Defined daily dose
- 60 mg, O
- Reimbursed
- Yes
- Last checked
- June 4, 2026
Packs & prices · 1
1 priced- aic050825037AQUIPTA*28 cpr 60 mgEUR 678.13
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same medicine, other countries
Atogepant in 15 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- CzechiaAQUIPTAAbbVie Deutschland GmbH & Co.KG, Ludwigshafen
- United StatesQuliptaAbbVie Inc.
- CanadaQULIPTAABBVIE CORPORATION
- FinlandAQUIPTAAbbVie Deutschland GmbH&Co.KG
- FranceAQUIPTA 10 mg, compriméABBVIE DEUTSCHLAND (ALLEMAGNE)
- United KingdomAquipta 10mg tabletsAbbVie Ltd
- BelgiumAquipta 10 mgAbbVie Deutschland
- IcelandAquiptaAbbVie Deutschland GmbH & Co. KG
Authorised across Europe · EMA
The same active substance is authorised in 4 EEA countries. Names it is sold under:
- United Kingdom (Northern Ireland) · Aquipta
- Iceland · Aquipta
- Liechtenstein · Aquipta
- Norway · Aquipta
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of the issuing authority. This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/e64b9bf9-89b4-4354-9f15-d4aaa459dcd6 GET /v1/drugs/e64b9bf9-89b4-4354-9f15-d4aaa459dcd6?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"price": 678.13,
"source": "aifa",
"currency": "EUR",
"strength": "ATOGEPANT 60MG 28 UNITA' USO ORALE",
"substance": "Atogepant",
"equivalence_group": "NDT",
"transparency_flag": null
}See everything about atogepant.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.